We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $167B
1-Year Est. Return 44.17%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+44.17%
3 Year Est. Return
+189.18%
5 Year Est. Return
+274.73%
10 Year Est. Return
+1,810.99%
AUM
$101B
AUM Growth
+$9.34M
Cap. Flow
-$3.68B
Cap. Flow %
-3.65%
Top 10 Hldgs %
32.07%
Holding
692
New
65
Increased
187
Reduced
376
Closed
50

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.02B
2
DIS icon
Walt Disney
DIS
+$913M
3
LULU icon
lululemon athletica
LULU
+$435M
4
NOW icon
ServiceNow
NOW
+$382M
5
TWLO icon
Twilio
TWLO
+$336M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$883M
2
RHT
Red Hat Inc
RHT
+$656M
3
UNH icon
UnitedHealth
UNH
+$601M
4
BMY icon
Bristol-Myers Squibb
BMY
+$543M
5
AZN icon
AstraZeneca
AZN
+$375M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Consumer Discretionary 16.29%
3 Healthcare 15.56%
4 Financials 12.45%
5 Communication Services 12.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRE icon
676
Spyre Therapeutics
SYRE
$7.97B
-31,044
Closed -$6.25M
TVTX icon
677
Travere Therapeutics
TVTX
$6.19B
-590,390
Closed -$13.4M
VTRS icon
678
Viatris
VTRS
$18.8B
-595,407
Closed -$16.9M
ONC
679
BeOne Medicines Ltd
ONC
$41.5B
-4,513
Closed -$596K
PXD
680
DELISTED
Pioneer Natural Resource Co.
PXD
-54,617
Closed -$8.32M
LTHM
681
DELISTED
Livent Corporation
LTHM
-139,161
Closed -$1.71M
FSTX
682
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-132,320
Closed -$5.55M
CTXS
683
DELISTED
Citrix Systems Inc
CTXS
-18,567
Closed -$1.85M
MNDT
684
DELISTED
Mandiant, Inc. Common Stock
MNDT
-893,052
Closed -$15M
EPZM
685
DELISTED
Epizyme, Inc
EPZM
-710,156
Closed -$8.8M
CVA
686
DELISTED
Covanta Holding Corporation
CVA
-87,520
Closed -$1.51M
GRUB
687
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-182,909
Closed -$25.4M
SEMG
688
DELISTED
SEMGROUP CORPORATION
SEMG
-653,071
Closed -$9.63M
CBLK
689
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-1,320,277
Closed -$18.4M
CHSP
690
DELISTED
Chesapeake Lodging Trust
CHSP
-56,319
Closed -$1.57M
RDC
691
DELISTED
Rowan Companies Plc
RDC
-567,597
Closed -$6.12M
ATVI
692
DELISTED
Activision Blizzard
ATVI
-3,853,104
Closed -$175M

Similar funds

Jennison Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Jennison Associates held 692 positions worth $101B, up 0.01% from $101B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jennison Associates withdrew a net $3.68B in Q2 2019, closing 50 positions and reducing 376 holdings. Its most notable exit was Activision Blizzard, an estimated $175M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Jennison Associates opened a new position in Uber worth $323M.

  • Jennison Associates's largest Q2 2019 buy was Uber: 6,953,868 shares worth $323M.
  • Jennison Associates added most to Qualcomm in Q2 2019, an estimated $1.02B increase.
  • Jennison Associates's biggest Q2 2019 reduction was Merck, cutting an estimated $883M.
  • Jennison Associates fully exited Activision Blizzard in Q2 2019, selling an estimated $175M.
  • Jennison Associates's ten largest holdings make up 32% of its $101B portfolio in Q2 2019.
  • Jennison Associates opened 65 new positions and closed 50 in Q2 2019.
  • Jennison Associates's portfolio value rose 0.01% quarter-over-quarter to $101B.

Based on Jennison Associates's 13F filing for Q2 2019, filed 6 Aug 2019.